PROKIDNEY CORP. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.79 USD | -3.32% |
|
+50.19% | +120.22% |
| May. 10 | ProKidney Q1 Loss Unchanged From Year Earlier | MT |
| May. 10 | ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 242M | - | - | - | - | - | |
| 50.85B | - | |||||
| 42.82B | ||||||
| 42.03B | ||||||
| 29.55B | ||||||
| 26.11B |
- Stock Market
- Equities
- PROK Stock
- Charts ProKidney Corp.
- Sector Chart